Exelixis Inc Gain (Loss) on Disposition of Other Assets
Exelixis Inc (EXEL) reported Gain (Loss) on Disposition of Other Assets of $2.49 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2016-11-03
- Exelixis Inc gain (loss) on disposition of other assets for the quarter ending 2016-09-30 was $2.49M.
- Exelixis Inc gain (loss) on disposition of other assets for the quarter ending 2016-06-30 was $0.00.
- Exelixis Inc gain (loss) on disposition of other assets for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc gain (loss) on disposition of other assets for the quarter ending 2015-12-31 was $17.00K.
- Exelixis Inc gain (loss) on disposition of other assets for fiscal 2015 was $112.00K, a 86.63% decline from fiscal 2014.
- Exelixis Inc gain (loss) on disposition of other assets for fiscal 2014 was $838.00K.
- Exelixis Inc gain (loss) on disposition of other assets for fiscal 2013 was $0.00.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|---|---|---|
| 2016-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.49M derived: sum of 2 quarters · filed 2016-11-03 | $2.49M 10-Q · filed 2016-11-03 | $2.51M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $17.00K derived: sum of 3 quarters · filed 2016-08-03 | $17.00K derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $17.00K derived: sum of 2 quarters · filed 2016-05-04 | $17.00K derived: sum of 3 quarters · filed 2016-11-03 | $17.00K derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $17.00K derived: sum of 2 quarters · filed 2016-11-03 | $17.00K derived: sum of 3 quarters · filed 2016-11-03 | $112.00K 10-K · filed 2016-02-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $95.00K 10-Q · filed 2016-11-03 | $95.00K derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $95.00K 10-Q · filed 2016-08-03 | $95.00K derived: sum of 3 quarters · filed 2016-08-03 | $933.00K derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | $95.00K 10-Q · filed 2016-05-04 | $95.00K derived: sum of 2 quarters · filed 2016-05-04 | $933.00K derived: sum of 3 quarters · filed 2016-05-04 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $838.00K derived: sum of 2 quarters · filed 2016-02-29 | $838.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $838.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $838.00K 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |